小野药品与Biohaven达成独家许可协议,将在日本、韩国、台湾及东盟开发并商业化IgG降解剂

美股速递
Oct 08

小野药品工业株式会社宣布,已与Biohaven Pharmaceutical Holding Co Ltd.签署一项独家许可协议。根据该协议,双方将在日本、韩国、台湾及东盟地区共同开发并商业化IgG降解剂。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10